Sign in

CIK 0001840706

  • Accelerated filer
  • Emerging growth company

SOPHiA GENETICS SA

Sign in to watch
Ticker
SOPH
Exchange
Nasdaq
Industry
Services-Computer Processing & Data Preparation
FY end
Dec 31
Incorporated
Switzerland
Entity type
Other
Phone
+41 216941060
Business address
LA PIECE, CH-1180, ROLLE, Switzerland, 00000
  1. 4/A Grant or award Chief Sales Officer acquired 56,468 shares (grant or award)
  2. 4/A Grant or award Chief People Officer acquired 71,869 shares (grant or award)
  3. 4/A Grant or award Chief Scientific Officer acquired 112,936 shares (grant or award)
  4. 4/A Grant or award Chief Technology Officer acquired 82,136 shares (grant or award)
  5. 4 Grant or award Chief Technology Officer acquired 82,136 shares (grant or award)
  6. 4 Grant or award President acquired 431,211 shares (grant or award)
  7. 4 Grant or award Chief Medical Officer acquired 112,936 shares (grant or award)
  8. 4 Grant or award Chief Scientific Officer acquired 112,936 shares (grant or award)
  9. 4 Grant or award Chief Executive Officer acquired 431,211 shares (grant or award)
  10. 4 Grant or award Chief Sales Officer acquired 56,468 shares (grant or award)
  11. 4 Grant or award Chief Financial Officer acquired 112,936 shares (grant or award)
  12. 4 Grant or award Chief People Officer acquired 71,869 shares (grant or award)
  13. 4 Grant or award Chief Legal Officer acquired 97,536 shares (grant or award)
  14. 4 Open-market sale Chief Sales Officer sold 3 shares at $4.71 ($14)
  15. 4 Planned sale Chief Legal Officer sold 684 shares at $4.79 ($3,274)
  16. 4 Planned sale Chief Executive Officer sold 4,486 shares at $4.77 ($21,410)
  17. 4 Planned sale Chief Medical Officer sold 608 shares at $4.79 ($2,913)
  18. 4 Planned sale Chief Scientific Officer sold 608 shares at $4.78 ($2,907)
  19. 4 Planned sale Chief People Officer sold 380 shares at $4.79 ($1,818)
  20. 4 Planned sale President sold 1,183 shares at $4.79 ($5,671)

Page 7 of 8 · 157 filings